News & AnalysisBrightseed racks up $68m Series BBrightseed, a biosciences company, has raised $68 million in Series B funding.ByIris Dorbian10 May 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs